Accelerate your product development. Master the exact ingredient synergistics, physical properties, and scalability engineering required for a best-in-class fisetin senolytic capsules.
This formulation leverages the flavonol fisetin to selectively induce apoptosis in senescent cells via the inhibition of pro-survival pathways like PI3K/AKT/mTOR, thereby reducing the systemic inflammatory burden associated with the senescence-associated secretory phenotype.
Nutraceuticals
The product targets the rapidly growing longevity and biohacking demographic seeking evidence-based interventions to mitigate age-related cellular decline and improve healthspan.
The following ingredients are scientifically relevant to this product category. Exact clinical doses, ratios, and excipient compatibility require a full formulation analysis.
→ Get the full formulation with exact doses, BOM, and regulatory compliance
Every commercial product format faces distinct physiochemical constraints during R&D. Here are the primary obstacles in scaling Fisetin Senolytic Capsules.
Fisetin exhibits poor aqueous solubility and rapid first-pass metabolism, necessitating advanced delivery systems like lipid-based carriers or micronization to achieve therapeutic plasma levels.
The polyphenolic structure is susceptible to oxidative degradation and pH-dependent instability during processing and storage, requiring protective antioxidants or specific capsule shell selections.
High-dose requirements for senolytic protocols can lead to manufacturing difficulties regarding powder flowability and capsule fill weight consistency in high-speed encapsulation equipment.
Stop guessing at ingredient ratios and excipient compatibility. Formulaite's AI R&D engine generates a peer-reviewed, regulatory-compliant, and physically stable formulation — complete with a manufacturer-ready BOM — in hours, not months.
Build Science-Backed Formulation